Nasdaq Adds Equity Rule Deficiency to Existing Bid Price Delisting Threat
AIDX sits 33% above its 52-week low of $0.401 on light trading volume (0.1× avg).
Summary
Nasdaq issued a second deficiency notice to 20/20 Biolabs, this time for stockholders' equity below the $2.5 million minimum, adding to the existing bid price delisting threat and shortening the company's runway to fix both issues.
Key Events · Legal and Risk Events · AIDX
-
New Equity Rule Deficiency
Nasdaq notified the company on September 3, 2026 that stockholders' equity of $1,620,700 (per the June 30, 2026 10-Q) falls below the $2,500,000 minimum required by Listing Rule 5550(b)(1).
-
45-Day Plan Deadline
The company has 45 calendar days to submit a plan to regain compliance; if accepted, Nasdaq may grant up to 180 days from the notification letter date to evidence compliance.
-
Bid Price Grace Period at Risk
If the Equity Rule is not cured by January 13, 2027, the company will not qualify for a second 180-day compliance period for the existing Bid Price Rule deficiency, effectively shortening the overall timeline.
-
Prior Bid Price Deficiency
The company was already under a 180-day compliance period (until January 13, 2027) to regain a $1.00 closing bid price, as disclosed in the July 22, 2026 8-K.
Analysis · AIDX · Industrial Applications And Services
20/20 Biolabs now faces two separate Nasdaq listing deficiencies. The new Equity Rule notice stems from stockholders' equity of $1,620,700 — well below the $2,500,000 minimum — and the company has only 45 days to submit a compliance plan. Critically, failure to fix the equity shortfall by January 13, 2027 eliminates the second 180-day grace period for the bid price rule, compressing the timeline to regain compliance. With the stock at $0.53 and a market cap near $7 million, the path to a $1.00 bid price or a $2.5 million equity raise is narrow, and the company remains reliant on toxic financing.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 43.9% of the 553 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AIDX was trading at $0.53 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.9M. The 52-week trading range was $0.40 to $50.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.